American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$224M |
| 2 |
BorgWarner
BWA
|
+$155M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$148M |
| 4 |
Booz Allen Hamilton
BAH
|
+$148M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$277M |
| 2 |
Meta Platforms (Facebook)
META
|
+$272M |
| 3 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$254M |
| 4 |
Gilead Sciences
GILD
|
+$217M |
| 5 |
Johnson & Johnson
JNJ
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.58% |
| 2 | Technology | 14.76% |
| 3 | Healthcare | 13.64% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Industrials | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
951
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.07M | ﹤0.01% |
181,009
-87,189
| -33% | -$1.33M |
|
952
Williams-Sonoma
WSM
$29.2B
| $3.05M | ﹤0.01% |
92,908
-18,300
| -16% | -$580K |
|
953
Marcus & Millichap
MMI
$1.2B
| $3.05M | ﹤0.01% |
87,796
+38,076
| +77% | +$1.44M |
|
|
MDCO
954
DELISTED
Medicines Co
MDCO
| $3.03M | ﹤0.01% |
101,401
-756
| -0.7% | -$28.5K |
|
955
AnaptysBio
ANAB
$1.65B
| $3.03M | ﹤0.01% |
30,355
-241
| -0.8% | -$20K |
|
|
UNT
956
DELISTED
UNIT Corporation
UNT
| $3M | ﹤0.01% |
114,943
+2,216
| +2% | +$57.6K |
|
957
HealthStream
HSTM
$841M
| $2.99M | ﹤0.01% |
96,345
+74,835
| +348% | +$2.24M |
|
958
Cheesecake Factory
CAKE
$5.83B
| $2.98M | ﹤0.01% |
55,690
-74,330
| -57% | -$4.02M |
|
959
iShares MSCI Taiwan ETF
EWT
$11.6B
| $2.97M | ﹤0.01% |
78,792
| – | – |
|
960
ManpowerGroup
MAN
$2.68B
| $2.95M | ﹤0.01% |
34,310
-49,607
| -59% | -$4.41M |
|
961
CytomX Therapeutics
CTMX
$734M
| $2.89M | ﹤0.01% |
156,248
+931
| +0.6% | +$21.2K |
|
|
ALDR
962
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.86M | ﹤0.01% |
171,976
-1,259
| -0.7% | -$22.8K |
|
963
Gold Fields
GFI
$35.4B
| $2.86M | ﹤0.01% |
1,181,100
+123,700
| +12% | +$372K |
|
|
PRNB
964
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.86M | ﹤0.01% |
+97,772
| New | +$2.76M |
|
|
ESIO
965
DELISTED
Electro Scientific Industries
ESIO
| $2.84M | ﹤0.01% |
162,928
-199,235
| -55% | -$3.88M |
|
|
ACOR
966
DELISTED
Acorda Therapeutics
ACOR
| $2.82M | ﹤0.01% |
+1,196
| New | +$3.7M |
|
967
Orthofix Medical
OFIX
$426M
| $2.81M | ﹤0.01% |
48,595
-101,599
| -68% | -$5.69M |
|
968
Turning Point Brands
TPB
$1.77B
| $2.79M | ﹤0.01% |
67,263
+50,118
| +292% | +$1.76M |
|
969
Ryman Hospitality Properties
RHP
$7.86B
| $2.74M | ﹤0.01% |
31,774
| – | – |
|
|
CSII
970
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.72M | ﹤0.01% |
+69,511
| New | +$2.57M |
|
971
Financial Institutions
FISI
$831M
| $2.72M | ﹤0.01% |
86,601
| – | – |
|
972
Helix Energy Solutions
HLX
$1.48B
| $2.7M | ﹤0.01% |
273,378
| – | – |
|
973
Laureate Education
LAUR
$5.19B
| $2.7M | ﹤0.01% |
+174,816
| New | +$2.69M |
|
|
UN
974
DELISTED
Unilever NV New York Registry Shares
UN
| $2.69M | ﹤0.01% |
48,071
+7,800
| +19% | +$441K |
|
975
Upland Software
UPLD
$16.3M
| $2.68M | ﹤0.01% |
8,291
+5,565
| +204% | +$1.93M |
|
Similar funds
American Century Companies's Q3 2018 Portfolio in Review
As of Q3 2018, American Century Companies held 1,415 positions worth $103B, up 3.2% from $99.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2018 filing shows 134 new, 562 increased, 487 reduced and 164 closed positions. Its largest new stake was DocuSign: 1,964,123 shares worth $103M. The largest sale was PepsiCo, an estimated $277M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2018 buy was DocuSign: 1,964,123 shares worth $103M.
- American Century Companies added most to Mondelez International in Q3 2018, an estimated $224M increase.
- American Century Companies's biggest Q3 2018 reduction was PepsiCo, cutting an estimated $277M.
- American Century Companies fully exited LKQ Corp in Q3 2018, selling an estimated $99M.
- American Century Companies's ten largest holdings make up 18% of its $103B portfolio in Q3 2018.
- American Century Companies opened 134 new positions and closed 164 in Q3 2018.
- American Century Companies's portfolio value rose 3.2% quarter-over-quarter to $103B.
Based on American Century Companies's 13F filing for Q3 2018, filed 2 Nov 2018.